Using AI to create a vaccine revolution
Clinical stage company Evaxion Biotech is using artificial intelligence (AI) to simulate the immune system and create predictive models to identify novel targets for vaccines against bacterial and viral diseases and immunotherapies for cancer.
Publication: Biopharma Dealmakers
By: Evaxion & Nature Research Custom Media
Scroll down to download the full publication